These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36641771)

  • 41. Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies.
    Dayan CM; Lecumberri B; Muller I; Ganesananthan S; Hunter SF; Selmaj KW; Hartung HP; Havrdova EK; LaGanke CC; Ziemssen T; Van Wijmeersch B; Meuth SG; Margolin DH; Poole EM; Baker DP; Senior PA
    Mult Scler J Exp Transl Clin; 2023; 9(1):20552173221142741. PubMed ID: 36619856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoimmune Thyroiditis Shifting from Hashimoto's Thyroiditis to Graves' Disease.
    Daramjav N; Takagi J; Iwayama H; Uchino K; Inukai D; Otake K; Ogawa T; Takami A
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes of IgG
    Trzos S; Link-Lenczowski P; Sokołowski G; Pocheć E
    Front Immunol; 2022; 13():841710. PubMed ID: 35370997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metamorphic thyroid autoimmunity in Down Syndrome: from Hashimoto's thyroiditis to Graves' disease and beyond.
    Aversa T; Valenzise M; Salerno M; Corrias A; Iughetti L; Radetti G; De Luca F; Wasniewska M
    Ital J Pediatr; 2015 Nov; 41():87. PubMed ID: 26558364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study.
    Zhukovsky C; Sandgren S; Silfverberg T; Einarsdottir S; Tolf A; Landtblom AM; Novakova L; Axelsson M; Malmestrom C; Cherif H; Carlson K; Lycke J; Burman J
    J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):189-194. PubMed ID: 33106366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID-induced thyroid autoimmunity.
    Brancatella A; Viola N; Santini F; Latrofa F
    Best Pract Res Clin Endocrinol Metab; 2023 Mar; 37(2):101742. PubMed ID: 36813660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TSH RECEPTOR ANTIBODIES: RELEVANCE & UTILITY.
    Kahaly GJ; Diana T; Olivo PD
    Endocr Pract; 2020 Jan; 26(1):97-106. PubMed ID: 32022598
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of alemtuzumab on neurodegeneration in relapsing-remitting multiple sclerosis: A five-year prospective mono-center study.
    Sandgren S; Novakova L; Nordin A; Sabir H; Axelsson M; Malmeström C; Zetterberg H; Lycke J
    Mult Scler Relat Disord; 2024 Nov; 91():105894. PubMed ID: 39293124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves' disease.
    Ze Y; Shao F; Feng X; Shen S; Bi Y; Zhu D; Zhang X
    BMC Endocr Disord; 2022 Dec; 22(1):319. PubMed ID: 36522617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic susceptibility in thyroid autoimmunity.
    Ban Y; Tomer Y
    Pediatr Endocrinol Rev; 2005 Sep; 3(1):20-32. PubMed ID: 16369210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Relationship Between Primary Thyroid Lymphoma and Various Types of Thyroid Autoimmunity: A Retrospective Cohort Study of 498 Cases, Including 9 Cases with Graves' Disease.
    Suzuki N; Watanabe N; Noh JY; Yoshimura R; Mikura K; Kinoshita A; Suzuki A; Mitsumatsu T; Fukushita M; Matsumoto M; Yoshihara A; Katoh R; Sugino K; Ito K
    Thyroid; 2022 May; 32(5):552-559. PubMed ID: 35229626
    [No Abstract]   [Full Text] [Related]  

  • 52. Low vitamin D status is associated with hypothyroid Hashimoto's thyroiditis.
    Kim D
    Hormones (Athens); 2016 Jul; 15(3):385-393. PubMed ID: 27394703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-glutamic acid decarboxylase antibody in Graves' disease is a possible indicator for the unlikelihood of going into remission with antithyroid agents.
    Yoshihara A; Isozaki O; Okubo Y; Takano K
    Endocr J; 2009; 56(2):269-74. PubMed ID: 19139594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pretreatment anti-thyroid autoantibodies indicate increased risk for thyroid autoimmunity secondary to alemtuzumab: A prospective cohort study.
    Ruck T; Schulte-Mecklenbeck A; Pfeuffer S; Heming M; Klotz L; Windhagen S; Kleinschnitz C; Gross CC; Wiendl H; Meuth SG
    EBioMedicine; 2019 Aug; 46():381-386. PubMed ID: 31371192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. METTL3 gene polymorphisms contribute to susceptibility to autoimmune thyroid disease.
    Song RH; Liu XR; Gao CQ; Du P; Zhang JA
    Endocrine; 2021 May; 72(2):495-504. PubMed ID: 33025559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of Graves' disease in children: The Portuguese experience.
    Marques O; Antunes A; Oliveira MJ
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):143-149. PubMed ID: 29325833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of Graves' hyperthyroidism: present and future.
    Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
    Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A real-life study of alemtuzumab in persons with multiple sclerosis: Kuwait's experience.
    Alroughani R; AlMojel M; Al-Hashel J; Ahmed SF
    Mult Scler Relat Disord; 2023 Jun; 74():104712. PubMed ID: 37054581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of thyroid dysfunction and autoantibodies in Graves' multiplex families: an eight-year follow-up study in Chinese Han pedigrees.
    Hou X; Li Y; Li J; Wang W; Fan C; Wang H; Zhang H; Shan Z; Teng W
    Thyroid; 2011 Dec; 21(12):1353-8. PubMed ID: 22029718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity.
    Bianco A; Nicoletti T; Traini E; Del Giacomo P; Del Gatto V; Lucchini M; Rota CA; Mirabella M
    J Endocrinol Invest; 2020 Aug; 43(8):1159-1161. PubMed ID: 32130689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.